In short-tempered markets, taking a long view can help investors maintain confidence.
24 March 2025European equities have started 2025 on a positive note. Several factors could help the market overcome challenging conditions.
Thorsten Winkelmann, Marcus Morris-Eyton | 18 March 2025The AI breakthrough spotlights some of China’s distinctive features that deserve closer attention from investors.
John Lin | 28 February 2025After the trade war’s opening salvoes, tensions seem set to last for some time.
Eric Winograd | 04 February 2025Not all companies in emerging markets will be hurt by President Trump’s agenda. Here’s what equity investors should look for.
Sammy Suzuki | 23 January 2025European equity markets may look vulnerable to fallout from new US policies. But some companies offer investors reasons to cheer.
Thorsten Winkelmann, Marcus Morris-Eyton | 21 January 2025Political uncertainty and volatility create fertile ground for active investors to find companies that can successfully navigate a new era.
Nelson Yu | 03 January 2025US elections could create fresh trade friction, increasing the impetus for Chinese companies to relocate key operations.
John Lin | 25 March 2024This is a marketing communication. This information is provided by AllianceBernstein Limited, 60 London Wall, London, EC2M 5SJ. Registered in England, No. 2551144. AllianceBernstein Limited is authorised and regulated in the UK by the Financial Conduct Authority (FCA - Reference Number 147956). It is provided for informational purposes only and does not constitute investment advice or an invitation to purchase any security or other investment. The views and opinions expressed are based on our internal forecasts and should not be relied upon as an indication of future market performance. The value of investments in any of the Funds can go down as well as up and investors may not get back the full amount invested. Past performance does not guarantee future results. This information is directed at Professional Clients only and is not intended for public use.